Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
Clinical trial NCT02025881 · TERMINATED
Trial details
- NCT number
- NCT02025881
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-14
- Primary completion
- 2020-10-25
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.